ASELAGE STEVE purchased 2.50K shares of BIOCRYST PHARMACEUTICALS INC on the open market
Open‑market purchase worth $16.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/29/2024ACC: 0001127602-24-016776
+2.50K
Net shares
Net buyer
$16.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.50K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+2.50K
Price / share
$6.40
Trade value
$16K
% of position
New position
5/24/2024
0.00→2.50K
Total
Net shares
+2.50K
Net value
$16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/24/2024 | P · Purchase | +2.50K | $6.40 | $16K | New position | 0.00 | 2.50K |
| Total | +2.50K | $16K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned63.34K
Total
63.34K direct63.34K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 63.34K | Direct |
| Total | 63.34K | 63.34K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported